CIK 0001674416
- Large accelerated filer
CRISPR Therapeutics AG
Sign in to watch- Ticker
- CRSP
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- Switzerland
- Entity type
- Operating
- EIN
- 473173478
- Phone
- +1 617-315-4600
- Business address
- BAARERSTRASSE 14, ZUG, Switzerland
- Former names
- CRISPR Therapeutics AG
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $4,881,673
- in 7 filings, $1.5M under 10b5-1 plans
Net −$4,881,673. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 60 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-26 | Patel Naimish Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +24,000 | 24,000 | ||
| 2026-10-26 | Patel Naimish Chief Medical Officer | Grant or award · Restricted Stock Units | +12,000 | 12,000 | ||
| 2026-05-29 | Patel Naimish Chief Medical Officer | Grant or award · Restricted Stock Units | +22,000 | 22,000 | ||
| 2026-05-29 | Patel Naimish Chief Medical Officer | Sale | −3,786 | $55.62 | $211K | 19,357 |
| 2026-05-28 | Patel Naimish Chief Medical Officer | Option exercise | +10,000 | 23,143 | ||
| 2026-05-28 | Patel Naimish Chief Medical Officer | Option exercise · Restricted Stock Units | −10,000 | 20,000 | ||
| 2026-03-20 | Patel Naimish Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +38,499 | 38,499 | ||
| 2026-03-20 | Patel Naimish Chief Medical Officer | Grant or award · Restricted Stock Units | +30,000 | 30,000 | ||
| 2026-03-16 | Patel Naimish Chief Medical Officer | Sale | −3,150 | $48.26 | $152K | 13,143 |
| 2026-03-14 | Patel Naimish Chief Medical Officer | Option exercise | +8,125 | 16,293 | ||
| 2026-03-14 | Patel Naimish Chief Medical Officer | Option exercise · Restricted Stock Units | −8,125 | 24,375 | ||
| 2025-10-03 | Patel Naimish Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +16,500 | 16,500 | ||
| 2025-05-30 | Patel Naimish Chief Medical Officer | Grant or award · Restricted Stock Units | +25,000 | 25,000 | ||
| 2025-05-29 | Patel Naimish Chief Medical Officer | Sale | −3,932 | $35.94 | $141K | 6,068 |
| 2025-05-28 | Patel Naimish Chief Medical Officer | Option exercise | +10,000 | 10,000 | ||
| 2025-05-28 | Patel Naimish Chief Medical Officer | Option exercise · Restricted Stock Units | −10,000 | 30,000 | ||
| 2025-04-03 | Patel Naimish Chief Medical Officer | Purchase | +1,508 | $32.96 | $50K | 1,508 |
| 2025-03-14 | Patel Naimish Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +46,667 | 46,667 | ||
| 2025-03-14 | Patel Naimish Chief Medical Officer | Grant or award · Restricted Stock Units | +32,500 | 32,500 | ||
| 2024-10-16 | Patel Naimish Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +18,333 | 18,333 |
Page 1 of 2 · 22 trades